The Arora Insights Blog

Scaling GLP-1 programs isn’t about volume — it’s about readiness. Our physician-led GLP-1 Readiness Checklist shares the operational and clinical areas clinics should review before seasonal demand peaks.

The removal of GLP-1s from the FDA shortage list fundamentally changed how these therapies may be prescribed, dispensed, and billed. Models that were once tolerated now carry meaningful regulatory risk.

Women deserve longevity strategies that are as intentional, data-guided, and proactive as those routinely offered to men. When women’s longevity is under-dosed, the limitation is not the therapy. It is the reluctance to apply it correctly.

Peptides are emerging as one of the most impactful tools in preventative and regenerative medicine. These targeted amino-acid chains support metabolism, cellular repair, immune function, recovery, and overall vitality, making them a natural fit for aesthetics, longevity, and wellness programs.

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring peptide that helps your skin and hair repair and renew themselves. Our bodies make less of it as we age, which can lead to slower healing, thinning hair, and loss of firmness or glow in the skin.

Arora Health & Aesthetics announced the national rollout of its physician-led operating platform designed for wellness and telehealth companies. Founded by Dr. Sean Arora, the company integrates national medical oversight, 50-state regulatory guidance, and telehealth infrastructure into one cohesive system so companies can scale responsibly.